"Anti-HIV Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS.
| Descriptor ID |
D019380
|
| MeSH Number(s) |
D27.505.954.122.388.077.088
|
| Concept/Terms |
Anti-HIV Agents- Anti-HIV Agents
- Agents, Anti-HIV
- Anti HIV Agents
- Anti-AIDS Agents
- Agents, Anti-AIDS
- Anti AIDS Agents
- Anti-HIV Drugs
- Anti HIV Drugs
- Drugs, Anti-HIV
- AIDS Drugs
- Drugs, AIDS
- Anti-AIDS Drugs
- Anti AIDS Drugs
- Drugs, Anti-AIDS
|
Below are MeSH descriptors whose meaning is more general than "Anti-HIV Agents".
Below are MeSH descriptors whose meaning is more specific than "Anti-HIV Agents".
This graph shows the total number of publications written about "Anti-HIV Agents" by people in this website by year, and whether "Anti-HIV Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 1998 | 0 | 2 | 2 |
| 1999 | 0 | 1 | 1 |
| 2000 | 5 | 1 | 6 |
| 2001 | 1 | 1 | 2 |
| 2002 | 2 | 0 | 2 |
| 2003 | 1 | 2 | 3 |
| 2004 | 5 | 0 | 5 |
| 2005 | 1 | 0 | 1 |
| 2006 | 3 | 3 | 6 |
| 2007 | 2 | 3 | 5 |
| 2008 | 3 | 0 | 3 |
| 2009 | 4 | 2 | 6 |
| 2010 | 4 | 4 | 8 |
| 2011 | 3 | 1 | 4 |
| 2012 | 5 | 2 | 7 |
| 2013 | 4 | 0 | 4 |
| 2014 | 1 | 3 | 4 |
| 2015 | 8 | 2 | 10 |
| 2016 | 6 | 3 | 9 |
| 2017 | 2 | 3 | 5 |
| 2018 | 1 | 0 | 1 |
| 2019 | 3 | 2 | 5 |
| 2020 | 4 | 3 | 7 |
| 2021 | 5 | 0 | 5 |
| 2022 | 3 | 0 | 3 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anti-HIV Agents" by people in Profiles.
-
Engaging?men?through HIV self-testing with differentiated care to improve ART initiation and viral suppression among men in Malawi (ENGAGE): A study protocol for a randomized control trial. PLoS One. 2023; 18(2):e0281472.
-
Efavirenz Pharmacokinetics and Human Immunodeficiency Virus Type 1 (HIV-1) Viral Suppression Among Patients Receiving Tuberculosis Treatment Containing Daily High-Dose Rifapentine. Clin Infect Dis. 2022 09 10; 75(4):560-566.
-
Casting a Wide Net: HIV Drug Resistance Monitoring in Pre-Exposure Prophylaxis Seroconverters in the Global Evaluation of Microbicide Sensitivity Project. Glob Health Sci Pract. 2022 04 28; 10(2).
-
Evaluation of a telemedicine pilot program for the provision of HIV pre-exposure prophylaxis in the Southeastern United States. AIDS Care. 2022 Dec; 34(12):1499-1505.
-
A Scoping Review Investigating Relationships between Depression, Anxiety, and the PrEP Care Continuum in the United States. Int J Environ Res Public Health. 2021 10 30; 18(21).
-
Perinatal Depressive Symptoms, Human Immunodeficiency Virus (HIV) Suppression, and the Underlying Role of Antiretroviral Therapy Adherence: A Longitudinal Mediation Analysis in the IMPAACT P1025 Cohort. Clin Infect Dis. 2021 10 20; 73(8):1379-1387.
-
The Use of Integrase Strand Transfer Inhibitors to Treat HIV in Pregnancy. J Midwifery Womens Health. 2021 May; 66(3):403-406.
-
"We are in this together:" dyadic-level influence and decision-making among HIV serodiscordant couples in Tanzania receiving access to PrEP. BMC Public Health. 2021 04 14; 21(1):720.
-
Long-Distance Travel for HIV-Related Care-Burden or Choice?: A Mixed Methods Study in Tanzania. AIDS Behav. 2021 Jul; 25(7):2071-2083.
-
The paradox of HIV prevention: did biomedical prevention trials show how effective behavioral prevention can be? AIDS. 2020 11 15; 34(14):2007-2011.